INS and chronic kidney disease: Patterns of use were quite similar among CKD, CVD, and HF patients in which insulin was more frequently prescribed (28.3%, 30.6%, and 35.7%, respectively) and, consequently, the percentage of high-risk antidiabetic drugs (49.0%, 49.8%, and 53.1%, respectively) (Table 1).